2m 2m 2m 2m 2m 2m 2m
Puma Biotech (PBYI)
NASDAQ
$6.82+$0.005 (+0.07%)
Price as of Jun 03, 2026 4:10 PM EDT- $364.9MMarket Cap
- 110.56%1-Year Change
- BiotechnologyIndustry
Puma Biotech (PBYI)
$6.82+$0.005 (+0.07%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 204.1M -11.45% | 230.5M -2.19% | 235.6M +3.34% | 228.0M -9.92% | |
Cost of Revenue | 58.2M -9.70% | 64.4M +2.75% | 62.7M +13.77% | 55.1M -13.51% | |
Gross Profit | 145.9M -12.13% | 166.1M -3.98% | 173.0M +0.010% | 172.9M -8.72% | |
Sales and Marketing Expense | 70.8M -11.62% | 80.2M -10.86% | 89.9M -0.05% | 90.0M -22.63% | |
Research and Development Expense | -62.1M +12.98% | -54.9M +9.04% | -50.4M -14.95% | -59.2M -17.57% | |
Depreciation and Amortization Expense | 10.9M -5.09% | 11.5M +0.04% | 11.5M +29.14% | 8.9M -15.83% | |
Total Operating Expenses | 191.1M -4.23% | 199.5M -1.72% | 203.0M -0.64% | 204.3M -18.88% | |
Operating Profit | 37.3M +20.45% | 31.0M -5.13% | 32.6M +37.61% | 23.7M +1,738.76% | |
Interest Income | 4.1M -13.67% | 4.7M +81.34% | 2.6M +220.42% | 813,000 +408.13% | |
Interest Expense | N/A N/A | -7.7M -42.24% | -13.3M +14.99% | -11.6M -9.49% | |
Interest Income and Expense and Net | 4.1M +237.03% | -3.0M -72.25% | -10.7M -0.50% | -10.8M -14.77% | |
Total Nonoperating Income and Expense | -1.5M -77.91% | -6.9M -31.11% | -10.0M -57.16% | -23.3M -22.69% | |
Income before Taxes | 35.8M +48.47% | 24.1M +6.29% | 22.7M +4,861.49% | 457,000 +101.59% | |
Income Taxes | 4.7M +175.61% | -6.2M -670.45% | 1.1M +138.02% | 455,000 +40.43% | |
Extraordinary Items | 0 N/A | 0 -100.00% | 625,000 N/A | N/A N/A | |
Net Income | 31.1M +2.75% | 30.3M +40.23% | 21.6M +1,079,450.00% | 2,000 +100.01% | |
Net Income from Continuing Operations Applicable to Common | 35.8M +48.47% | 24.1M +6.29% | 22.7M +4,861.49% | 457,000 +101.59% | |
Basic EPS and Net Income | 0.62 0.00% | 0.62 +34.78% | 0.46 N/A | 0.00 +100.00% | |
Diluted EPS and Net Income | 0.61 -1.61% | 0.62 +37.78% | 0.45 N/A | 0.00 +100.00% | |
Basic Weighted Average Shares | 50.0M +2.80% | 48.6M +3.21% | 47.1M +5.51% | 44.7M +9.93% | |
Diluted Weighted Average Shares | 50.7M +3.16% | 49.1M +3.26% | 47.6M +5.83% | 44.9M +10.56% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 29.6M -57.19% | 69.2M -18.17% | 84.6M +11.00% | 76.2M +20.70% | |
Short-Term Investments | 67.9M +113.86% | 31.7M +179.60% | 11.4M +133.00% | 4.9M -74.32% | |
Cash and Cash Equivalents and Short-Term Investments | 97.5M -3.40% | 101.0M +5.24% | 95.9M +18.34% | 81.1M -1.26% | |
Total Current Assets | 162.7M +10.18% | 147.7M -5.46% | 156.2M +16.31% | 134.3M -4.10% | |
Accumulated Depreciation | 4.6M -41.56% | 7.9M +2.45% | 7.7M +3.42% | 7.4M +8.23% | |
Property and Plant and Equipment and Net | 187,000 -63.69% | 515,000 -39.77% | 855,000 -25.39% | 1.1M -34.74% | |
Total Long-Term Assets | 187,000 -63.69% | 515,000 -39.77% | 855,000 -25.39% | 1.1M -34.74% | |
Total Assets | 216.3M +1.39% | 213.3M -7.46% | 230.5M +3.81% | 222.1M -2.00% | |
Income Taxes Payable | 50.0M +35.15% | 37.0M -29.94% | 52.8M -12.55% | 60.4M -35.37% | |
Total Short-Term Debt | 22.5M -50.31% | 45.3M +33.33% | 34.0M N/A | N/A N/A | |
Total Current Liabilities | 81.3M -15.46% | 96.1M -3.29% | 99.4M +28.26% | 77.5M -29.29% | |
Total Long-Term Debt | 0 -100.00% | 21.7M -66.92% | 65.7M -33.21% | 98.3M +1.25% | |
Total Long-Term Liabilities | 0 -100.00% | 121,000 -99.83% | 72.7M -34.00% | 110.1M -2.59% | |
Total Liabilities | 86.0M -29.08% | 121.2M -31.55% | 177.1M -11.66% | 200.5M -12.48% | |
Retained Earnings | -1.3B -2.37% | -1.3B -2.25% | -1.3B -1.58% | -1.4B -0.0001% | |
Total Stockholders Equity | 130.3M +41.48% | 92.1M +72.38% | 53.4M +147.33% | 21.6M +983.40% | |
Total Shares Outstanding | 50.4M +2.65% | 49.1M +3.06% | 47.6M +15.72% | 41.2M +2.72% | |
Cash Flow | |||||
Cash from Operating Activities | 41.8M +7.41% | 38.9M +44.09% | 27.0M +270.65% | -15.8M -176.64% | |
Capital Expenditures | 71,000 +26.79% | 56,000 -60.00% | 140,000 N/A | 0 N/A | |
Cash from Investing Activities | -36.2M +77.06% | -20.4M +6.87% | -19.1M -369.21% | 7.1M +165.29% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -45.2M +33.54% | -33.8M N/A | 0 -100.00% | 12.2M +138.28% | |
Financials Ratio | |||||
Gross Margin | 71.50% -0.77% | 72.06% -1.83% | 73.40% -3.22% | 75.84% +1.34% | |
Operating Margin | 18.28% +36.03% | 13.44% -3.00% | 13.85% +33.16% | 10.40% +1,941.23% | |
Return on Assets | 14.48% +6.15% | 13.64% +42.99% | 9.54% +1,060,022.22% | 0.0009% +100.01% | |
Return on Equity | 27.97% -32.77% | 41.60% -27.70% | 57.54% +275,199.52% | 0.02% -100.00% | |
Revenue Growth | -11.45% +422.08% | -2.19% -165.77% | 3.34% +133.61% | -9.92% -179.66% | |
Current Ratio | 2.00 +30.33% | 1.54 -2.25% | 1.57 -9.31% | 1.73 +35.63% | |
Cash Ratio | 0.36 -49.36% | 0.72 -15.38% | 0.85 -13.45% | 0.98 +70.70% | |
Debt-to-Equity Ratio | 0.17 -76.26% | 0.73 -60.97% | 1.86 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.10 -66.88% | 0.31 -27.30% | 0.43 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow